B. Bulman

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Andrew Shenton, Sheila Seal, Anthony Howell, 2006, European journal of cancer.

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

A. Howell, D. Evans, F. Lalloo, 2010, British Journal of Cancer.

Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay.

S. Roberts, W. Burrill, D. Scott, 2000, International journal of radiation biology.

An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.

A. Howell, D. Evans, J. Varley, 1998, Journal of medical genetics.

Jews . mutations in a population of Ashkenazi An evaluation of common breast cancer gene

A. Howell, J. Varley, S. Cochrane, 2022 .

Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?

D. Evans, S. Roberts, D. Scott, 1999, American journal of human genetics.

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

L. Kiemeney, R. Eeles, Z. Kote-Jarai, 2014, European urology.

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

Katherine M. Tucker, L. Kiemeney, H. Grönberg, 2011, BJU international.